Serotonin receptor subtypes involved in the spinal antinociceptive effect of 5-HT in rats

Pain

Volumn 86, Issue 1-2, 2000, Pages 11-18

  Bardin, Laurent ^a   Lavarenne, Jeannine ^a   Eschalier, Alain ^a  

^a INSERM   (France)

Author keywords

5 HT receptor subtype; Mechanical pain test; Nociception; Rat; Serotonin; Spinal cord

Indexed keywords

1 (3 CHLOROPHENYL)BIGUANIDE; 1 METHYL 3 INDOLECARBOXYLIC ACID [1 [2 (METHYLSULFONYLAMINO)ETHYL] 4 PIPERIDINYLMETHYL] ESTER; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; KETANSERIN; MESULERGINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PENBUTOLOL; RECEPTOR SUBTYPE; SEROTONIN; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; TROPISETRON;

ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; MALE; MECHANICAL STRESS; NONHUMAN; PAIN THRESHOLD; PRESSURE; PRIORITY JOURNAL; RAT; SPINAL CORD;

ANALGESICS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, SPINAL; MALE; PAIN MEASUREMENT; PAIN THRESHOLD; PIPERAZINES; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT3; RECEPTORS, SEROTONIN, 5-HT4; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 0034193681     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(99)00307-3     Document Type: Article

References (70)

1. 3 receptor regulation of extracellular GABA levels in the prefrontal cortex. Neuropsychopharmacology. 20:1999;92-96.
2. 1B receptor subtypes in modulating spinal nociceptive transmission in mice. J Pharmacol Exp Ther. 265:1993;378-385.
3. 3 receptor mediated antinociception: possible release of GABA. J Neurosci. 11:1991;1881-1888.
4. 1 agonists and antagonists on nociceptive processing in the rat spinal cord: results from behavioral and electrophysiological studies. Brain Res. 661:1994;83-90.
5. 3 receptors in nociceptive processing in the rat spinal cord: results from behavioral and electrophysiological studies. Neurosci Lett. 208:1996;203-207.
6. Alloui A., Pélissier T., Dubray C., Lavarenne J., Eschalier A. Tropisetron inhibits the antinociceptive effect of intrathecally administered paracetamol and serotonin. Fundam Clin Pharmacol. 10:1996;406-407.
7. Bardin L., Bardin M., Lavarenne J., Eschalier A. Effect of intrathecal serotonin on nociception in rats: influence of the pain test used. Exp Brain Res. 113:1997;81-87.
8. 3 receptor antagonists on spinal serotonin-induced analgesia in rats. Brain Res. 765:1997;267-272.
9. Barnes N.M., Sharpe T.S. A review of central 5HT receptors and their function. Neuropharmacology. 38:1999;1083-1152.
10. Basbaum A.I., Godefroy F., Weil-Fugazza J. A new microdissection technique for regional analysis of the rat spinal cord: serotonin, norepinephrine, dopamine and acid uric. Brain Res. 419:1987;229-238.
11. Berendsen H.H.G., Broekkamp C.L.E. Behavioral evidence for functional interactions between 5-HT-receptor subtypes in rats and mice. Br J Pharmacol. 101:1990;667-673.
12. Berendsen H.H.G., Smets R.J.M., Broekkamp C.L.E. Functional interplay of serotonin (5-HT) receptor subtypes. Bevan P., Cools A.R., Archer T. The behavioral pharmacology of 5-HT. 1989;83-86 Lawrence Earlbaum, New York.
13. Cesselin F., Laporte A.M., Miquel M.C., Bourgoin S., Hamon M. Serotonergic mechanisms of pain control. Gebhart G.F., Hammond D.L., Jensen T.S. Progress in pain research and management, vol 2, proceedings of the VIIth World Congress on Pain. 1994;669-695 IASP, Seattle, WA.
14. Cohen M.L., Fuller R.W. Antagonism of vascular serotonin receptors by m-chlorophenyl piperazine and m-trifluoromethylphenylpiperazine. Life Sci. 32:1983;711-718.
15. Crisp T., Stafinsky J.L., Spanos L.J., Uram M., Perni V., Donepudi H.B. Analgesic effects of serotonin and receptor selective serotonin agonists in the rat spinal cord. Gen Pharmacol. 22:1991;247-251.
16. 3 receptor subtypes modulate responses to noxious colorectal distension in the rat. Brain Res. 538:1991;64-75.
17. Eide P.K., Tjolsen A. Effects of serotonin receptor antagonists and agonists on the tail-flick responses in mice involve altered tail skin temperature. Neuropharmacology. 27:1988;889-893.
18. 2 receptors in spinal cord in the control of nociceptive responsiveness. Neuropharmacology. 30:1991;727-731.
19. 1B receptors in the modulation of a spinal nociceptive reflex. Brain Res. 536:1990;195-200.
20. Eschalier A., Montastruc J.L., Devoize J.L., Rigal F., Gaillard-Plaza G., Pechadre J.C. Influence of naloxone and methysergide on the analgesic effect of clomipramine in rats. Eur J Pharmacol. 74:1981;1-9.
21. 3 receptors. Brain Res. 788:1998;20-24.
22. Fasmer O.B., Berge O.G., Hole K. Changes in nociception after lesions of descending serotoninergic pathways induced with 5,6-dihydroxytryptamine. Neuropharmacology. 24:1985;729-734.
23. Fleetwood-Walker S.M., Hope P.J., Mitchell R. Antinociceptive actions of descending dopaminergic tracts on cat and rat dorsal horn somatosensory neurons. J Physiol. 399:1988;335-348.
24. Fuxe K., Agnati L., Mascagni F., Kuga S., Helmer-Matyjek E., Goldstein M. Central dopamine agonist activity on the 8-a-amino-ergoline CU 32-085. Brain Res. 328:1985;325-332.
25. 4 agonists: BIMU 1 and BIMU 8. Life Sci. 58:1996;2297-2309.
26. Giordano J. Analgesic profile of centrally administered 2 methylserotonin against acute pain in rats. Eur J Pharmacol. 199:1991;233-236.
27. 3 receptor antagonist. Neurosci Lett. 95:1988;313-317.
28. Glaum S.R., Proudfit H.K., Anderson E.G. 5HT3 receptors modulate spinal nociceptive reflexes. Brain Res. 510:1990;12-16.
29. Glennon R.A., Lucki I. Behavioral models of serotonin receptor activation. Sanders-Bush E. The serotonin receptors. 1988;253-293 Humana, Clifton, NJ.
30. 7 receptor in rat brain. Br J Pharmacol. 117:1996;657-666.
31. Hamon M., Bourgoin S. Serotonin and its receptors in pain control. Sawynok J., Cowan A. Novel aspects of pain management: opioids and beyond. 1999;203-228 Wiley-Liss, New York.
32. Hole K., Tjolsen A. The tail-flick and formalin tests in rodents: changes in skin temperature as a confounding factor. Pain. 53:1993;247-254.
33. Hole K., Berge O.G., Eide P.K., Fasmer O.B., Hunskaar S., Lund A., Rostand J.H., Tjolsen A. Modifications in nociceptive reactivity following various serotonergic treatments: methodological difficulties. Besson J.M. Serotonin and pain. 1990;137-152 Elsevier, Amsterdam.
34. Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R., Mylecharane E.J., Saxena P.R., Humphrey P.P.A. Classification of receptors for 5-hydroxytryptamine. Pharmacol Rev. 46:1994;157-203.
35. 2 receptor antagonists. Brain Res. 612:1989;289-298.
36. 3 receptor agonist. Eur J Pharmacol. 182:1990;193-197.
37. Kuraishi Y., Hirota N., Satoh M., Takagi H. Antinociceptive effects of intrathecal opioids, noradrenaline and serotonin in rats: mechanical and thermal algesic tests. Brain Res. 326:1985;168-171.
38. 3 in the aged human spinal cord. J Chem Neuroanat. 11:1996;67-75.
39. Lin Q., Willis W.D. Application of methylsergide by microdialysis attenuates the inhibition of primate nociceptive spinothalamic tract neurons produced by stimulation in periaqueductal gray. Soc Neurosci Abstr. 19:1993;523.
40. Lin Q., Peng Y.B., Willis W.D. Antinociception and inhibition from the periaqueductal gray are mediated in part by spinal 5-hydroxytryptamine1A receptors. J Pharmacol Exp Ther. 276:1996;958-967.
41. Liu M.Y., Su C.F., Lin M.T. The antinociceptive role of bulbospinal serotonergic pathway in the rat brain. Pain. 33:1988;123-129.
42. Martin G.R., Humphrey P.P.A. Receptors for 5-hydroxytryptamine: current perspectives on classification and nomenclature. Neuropharmacology. 33:1994;261-273.
43. Mestre C., Pélissier T., Fialip J., Wilcox G., Eschalier A. A method to perform direct transcutaneous intrathecal injection in rats. J Pharmacol Toxicol Methods. 32:1994;197-200.
44. 2 receptors induces an analgesia involving an opioidergic but not enkephalinergic link. Eur J Pharmacol. 187:1990;201-207.
45. 1A receptors does not elicit antinociception against noxious thermal, mechanical and chemical stimuli in mice. Pain. 58:1994;45-61.
46. Millan M.J. The role of descending noradrenergic and serotoninergic pathways in the modulation of nociception: focus on receptor multiplicity, Handbook of experimental pharmacology, Vol. 130. Dickenson A.H., Besson J.M. The pharmacology of pain. 1997;385-446 Springer, Heidelberg.
47. 1A receptor-mediated activity. J Pharmacol Exp Ther. 256:1991;973-982.
48. 1B receptors in spinal nociceptive transmission and in the modulation of NMDA-induced behaviour. NeuroReport. 3:1992;1061-1064.
49. 2A receptor subtypes in modulating behaviour induced by excitatory amino acid receptor agonists in mice. Brain Res. 626:1993;78-82.
50. Murphy A.Z., Murphy R.M., Zemlan F.P. Role of spinal serotonin 1 receptor subtypes in thermally and mechanically elicited nociceptive reflexes. Psychopharmacology. 108:1992;123-130.
51. Oyama T., Ueda M., Kuraishi Y., Akaike A., Satoh M. Dual effect of serotonin on formalin-induced nociception in the rat spinal cord. Neurosci Res. 25:1996;129-135.
52. 3 receptors. Neuroreport. 6:1995;1546-1548.
53. 3 receptors in periaqueductal gray induced inhibition of nociceptive dorsal horn neurons in rats. J Pharmacol Exp Ther. 276:1996;116-124.
54. Randall L.O., Selitto J.J. A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn. 61:1957;409-417.
55. Saito Y., Collins J.G., Iwasaki H. Tonic 5-HT modulation of spinal dorsal horn neuron activity evoked by both noxious and non noxious stimuli: a source of neuronal plasticity. Pain. 40:1990;205-219.
56. Sanders-Bush E., Burris K.D., Knoth K. Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis. J Pharmacol Exp Ther. 246:1988;924-928.
57. Sawynok J., Reid A. Noradrenergic mediation of spinal antinociception by 5-hydroxytryptamine: characterization of receptor subtypes. Eur J Pharmacol. 223:1992;49-56.
58. 3 receptor agonists following 5,7 dihydroxytryptamine. Eur J Pharmacol. 264:1994;249-257.
59. Shannon M., Battaglia G., Glennon R.A., Titeler M. 5-HT1 and 5-HT2 binding properties of derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane (2,5 DMA). Eur J Pharmacol. 102:1984;23-29.
60. Solomon R.E., Gebhart G.F. Mechanisms of effects of intrathecal serotonin on nociception and blood pressure in rats. J Pharmacol Exp Ther. 245:1988;905-912.
61. Sugiyama B.H., Huang L.Y.M. Activation of 5-HT2 receptors potentiates the spontaneous inhibitory postsynaptic currents on (sIPSCs) intrigeminal neurons. Am Soc Neurosci Abstr. 21:1995;1415.
62. Takeshita N., Yamaguchi I. Meta-chlorophenylpiperazine attenuates formalin-induced nociceptive responses through 5-HT1/2 receptors in both normal and diabetic mice. Br J Pharmacol. 116:1995;3133-3138.
63. Tjolsen A., Berge O.G., Hole K. Lesions of bulbo-spinal serotoninergic or noradrenergic pathways reduce nociception as measured by the formalin test. Acta Physiol Scand. 142:1991;229-236.
64. 1A receptors. 1987;140-151 Horwood, Chichester.
65. Ward R.P., Hamblin M.W., Lachowicz J.E., Hoffman B.J., Sibley D.R., Dorsa D.M. Localisation of serotonin subtype 6 receptor messenger RNA in the rat brain by in situ hybridization histochemistry. Neuroscience. 64:1995;1105-1111.
66. Wilcox G.L., Alhaider A.A. Nociceptive and antinociceptive action of serotonin agonists administered intrathecally, Excerpta Medica International Congress Series, Vol. 879. Besson J.M. Serotonin and pain. 1990;205-219 Excerpta Medica, Amsterdam.
67. Xu W., Qiu X.C., Han J.S. Serotonin receptor subtypes in spinal antinociception in the rat. J Pharmacol Exp Ther. 269:1994;1182-1189.
68. 3 receptor. Brain Res. 533:1990;46-52.
69. Yaksh T.L., Wilson P.R. Spinal serotonin terminal system mediates antinociception. J Pharmacol Exp Ther. 208:1979;446-453.
70. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:1983;109-110.